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Case report
A 66-year-old male, scheduled for an elective thyroidec-
tomy following a recently diagnosed papillary thyroid car-
cinoma, presented with progressive dyspnea. His past 
medical history was significant for type-II diabetes, hyper-
lipidemia, HIV, and hepatitis C-related cirrhosis. His man-
agement included diabetic diet, atorvastatin, and highly 
active anti-retroviral therapy (HAART). He denied any 
prior cardiac history or coronary interventions. Given his 
cardiac risk factors and limited exercise tolerance, he was 
referred for myocardial SPECT imaging as a part of  the 
pre-operative workup. Rest images were obtained 30 min-
utes following the administration of  12.5 mCi of  99mTc-
sestamibi, and then stress images were obtained 45 minutes 
after injection of  36.5 mCi of  99mTc-sestamibi during a 
dipyridamole infusion. 
A review of  the raw projected cine images demonstrated 
diffusely increased pulmonary uptake of  the radiotracer 
both at rest and under stress (Figs. 1 and 2). 
The lung/heart ratio (LHR) was 0.62 at rest and 0.63 
under stress (normal value: 0.42). The LHR is measured by 
drawing the region of  interest over the anterolateral wall of 
the myocardium and over the mid to lower third of  the 
lung. Further interpretation of  the perfusion and gated 
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Technetium-99m (99mTc) sestamibi myocardial perfusion scintigraphy (MPI) is widely used for the diag-
nosis and assessment of  prognosis in patients with suspected coronary artery disease. During these inves-
tigations, inspection of  raw projected data for the purpose of  quality control may occasionally yield inci-
dental noncardiac findings that suggest the presence of  another primary noncardiac disease. We present 
a 66-year-old HIV patient with a tissue diagnosis of  lymphoid interstitial pneumonitis (LIP), who dem-
onstrated a diffuse increase of  99mTc-sestamibi in bilateral lung fields both in rest and stress MPI.
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Figure 1. 66-year-old male with HIV-associated lymphocytic 
interstitial pneumonitis. 99mTc-sestamibi resting images of 
the heart show diffusely increased pulmonary uptake of the 
radiotracer.
tomographic images demonstrated a normal perfusion pat-
tern under stress and at rest, normal LV wall motion, nor-
mal LV volumes, and an ejection fraction of  62% 
(normal > 55%). 
Based on the normal MPI findings and the diffuse pul-
monary uptake of  the radiotracer, we investigated addi-
tional correlative imaging. A review of  the patient's prior 
chest x-ray showed the presence of  diffuse, bilateral reticu-
lonodular lung opacities that were more prominent at the 
bases (Fig. 3). 
Chest CT examination revealed a similar distribution of  
a patchy ground-glass appearance throughout both lungs 
(Fig. 4). 
These findings were consistent with a generalized 
infectious/inflammatory pulmonary pathology. However, in 
this patient with primary thyroid carcinoma, radiological 
findings could not altogether rule out the presence of  meta-
static pulmonary disease. The patient subsequently under-
went a transbronchial lung biopsy, which confirmed the 
findings of  lymphoid interstitial pneumonitis (LIP) (Fig. 5). 
The cultures of  the bronchial brushings obtained during 
the tissue biopsy were negative for infectious etiology, in-
cluding bacterial and fungal organisms. Serum titers for 
Epstein Barr virus were also negative. 
Discussion
Although 99mTc-sestamibi was developed initially as an 
agent for MPI, several studies have shown that it accumu-
lates in cardiac and extracardiac tissues, depending on the 
etiologic processes involved. An intense and discrete uptake 
of  the radiotracer is commonly seen with viable tumors 
including thyroid (1), breast (2, 3), lung cancers, lymphomas 
(4, 5, 6), musculoskeletal sarcomas (7), and carcinoid tumors 
(8); focal inflammatory processes and pulmonary throm-
boembolism (PE) (9) also demonstrate a similar uptake. On 
the other hand, a diffuse increase in the pulmonary uptake 
of  99mTc-sestamibi occurs in a variety of  inflammatory and 
hypermetabolic processes affecting the myocardial and 
pulmonary tissues.
HIV-associated lymphocytic interstitial pneumonitis causes diffuse sestamibi lung uptake in MPI
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Figure 4. 66-year-old male with HIV-associated lymphocytic 
interstitial pneumonitis. Axial CT of the chest shows patchy 
ground-glass appearance throughout both lungs. 
Figure 2. 66-year-old male with HIV-associated lymphocytic 
interstitial pneumonitis. 99mTc-sestamibi stress images of the 
heart show diffusely increased pulmonary uptake of the 
radiotracer.
Figure 3. 66-year-old male with HIV-associated lymphocytic 
interstitial pneumonitis. PA radiograph of the chest shows 
diffuse, bilateral reticulonodular lung opacities most promi-
nent at the bases.
The exact mechanisms underlying the 99mTc-sestamibi 
uptake in the different etiologies mentioned thus far are not 
clearly understood. They are thought to relate to the radio-
pharmaceuticals’ chemical characteristics, the cationic 
charge, the lipophilic properties, and the negative trans-
membrane potentials generated in the cytoplasm and mito-
chondria of  metabolically active cells (10). In order to seek 
additional correlative tests and to establish a diagnosis, it is 
vital to have knowledge of  the differential conditions that 
result in the increased uptake of  99mTc-sestamibi as well as 
the pharmacokinetic characteristics of  the MPI radiotracer 
used.
In the present case, diffusely increased lung uptake of  
99mTc-sestamibi was noted on routine MPI SPECT both 
under stress and at rest. The increased uptake can be easily 
quantified as LHRs both under stress and at rest by draw-
ing regions of  interest in the upper lung field and the an-
terolateral wall of  the myocardium in the anterior planar 
views. Elevated LHRs in patients referred for MPI with 
suspected or confirmed cardiac disease are known to corre-
late well with the degree and severity of  left ventricular 
systolic dysfunction (LVSD) and angiographic coronary 
artery disease (CAD). In the absence of  cardiac disease (11, 
12, 13, 14), these findings may indicate the presence of  
underlying pulmonary processes. However, LHRs by MPI 
are nonspecific in discriminating between the various pul-
monary etiologies. 
Some of  these etiologies include chronic smoking (15), 
chemical pneumonitis (16), atypical pneumonias (P. carinii, 
MAC), and interstitial pneumonitis secondary to systemic 
sclerosis (17), all of  which were ruled out in our patient. 
Rarely, HIV is known to cause LIP, which is an inflamma-
tory reaction of  the lung interstitium to the virus. In the 
absence of  the aforementioned etiologies and the presence 
of  HIV infection, the radiotracer uptake in both the lungs 
as seen in our patient may most likely represent LIP. 
LIP is an inflammatory, lymphoproliferative, nonneoplas-
tic process representing a pulmonary reaction to various 
external stimuli or systemic diseases. It appears that a tran-
sient lymphocytic alveolitis develops in some HIV-positive 
patients as an immune response to the HIV virus, which in 
a certain percentage of  individuals evolves into LIP (18). 
The classical radiograph presentation is of  bilateral, pre-
dominantly lower-zone nodular or reticulonodular opacities 
with or without variable areas of  consolidation. On HRCT, 
this corresponds to patchy bilateral and diffuse ground-glass 
opacities (19). 
The imaging findings represent a summation of  lym-
phoid cellular infiltrates noted histologically within the lung 
interstitium. Since 99mTc-sestamibi is known to be taken up 
by inflammatory cells, the presence of  lymphoid infiltrates 
in the interstitium of  the lungs might explain the isolated 
findings of  bilateral diffusely increased uptake of  the radio-
tracer throughout both the lung fields with normal myo-
cardial perfusion and function. However, neither the MPI 
findings nor the radiological image findings are specific, so 
a tissue biopsy and histologic examination is warranted to 
confirm the diagnosis of  LIP (20). Thus, it is reasonable to 
conclude that the development of  LIP in our patient may 
have been entirely due to his HIV infection, since all other 
possible etiologies have been excluded.
While LIP is known to be one of  the criteria for defining 
acquired immunodeficiency syndrome (AIDS) in children, 
it is still considered unusual in HIV-positive adults (21). It is 
often an incidental finding rather than the patient’s present-
ing complaint, since the disease follows an indolent course, 
in stark contrast to the acute nature of  HIV-related pulmo-
nary infections. Thus, clinically this case is unique in that 
the patient presented with progressive dyspnea arising pre-
sumably from a HIV-associated LIP. Further, the presence 
of  cardiac risk factors and an underlying primary malig-
nancy complicated the diagnosis, requiring a complete 
workup including several imaging modalities before con-
firmation with tissue cultures and biopsy.
Conclusion
Although HIV-associated LIP in adults is unusual, 
knowledge of  its presence is particularly important in inter-
pretation of  those subgroups undergoing 99mTc-sestamibi 
MPI scans where HIV and cardiac risk factors are known 
to coexist. A careful and systematic review of  the raw pro-
jection data in these patients is therefore essential both for 
the purpose of  quality control and to detect noncardiac 
findings that may guide further workup for appropriate 
relevance (22). 
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